Henceforth, payment of dividends is carried out automatically through the Central Securities Depository or investment intermediaries to the existing bank account of the shareholder, in accordance with the procedure established by law.
DEAR SHAREHOLDER!
On the basis of the Law No. ZRU-1057 dated 17.04.2025. “On making amendments and additions to some legislative acts of the Republic of Uzbekistan“ amendments were made to the Law of the Republic of Uzbekistan ‘On Joint Stock Companies and Protection of Shareholders’ Rights”. Henceforth, payment of dividends is carried out automatically through the Central Securities Depository or investment intermediaries to the existing bank account of the shareholder, in accordance with the procedure established by law. At the same time, the JSC has no right to demand from the shareholder an application for payment of dividends.
The Central Securities Depository has implemented the function of payment of income on securities (dividends and interest), and in recent years, as a result of improvement of this area, opportunities have been created:
- realization of income payments (dividends and interest);
- mobile application service “UzCSD” (for individuals), which allows making quick payments in 24/7 mode, as well as managing own funds.
Management of “BIOKIMYO” JSC offers you to apply to the Central Securities Depository and install mobile application “UzCSD” in order to receive dividends.
Address of the Central Securities Depository:
100000, Tashkent, Mirzo-Ulugbek district, 107, Mustakillik Avenue,
Reference point: Buyuk Ipak yuli (M. Gorky) metro station, Uzcharmsanoat,
Contacts: (71) 211 09 09 (internal number: from 161 to 172).
For more information you can address to the address of Yangiyul, Kimegar Street №1, JSC “BIOKIMYO”. Tel: +95 177 30 75.
Administration
Latest news
Based on the results of the assessment of the company's corporate governance system for the of 12 month 2024 year: “LEADER FINANCE CAPITAL” i submitted a report on the assessment of the corporate department of the Company No. 21/02 dated fevral 13, 2025. According to the results of the evaluation of the corporate management system, the final number of points amounted to 1033 points, that is, 86,0 %, and according to “LEADER FINANCE CAPITAL”, the corporate control system in Biokimyo JSC according to the results of the 12 month of 2024 is recognized High" As a result of the study of the assessment of the corporate governance system, revealed: Notes on not following Codex recommendations Explanation II. Assessment of compliance with the recommendations of the Corporate Governance Code. clause 14. The composition of the Supervisory Board of JSC are not independent of the Supervisory Board The new composition of the Supervisory Board was elected at the extraordinary general meeting of shareholders on june 29, 2024, where independent candidates participated, but they did not receive the largest votes during the voting VII. Evaluation of information policy p.1.12, p.1.13, p.2.12, p.3.12. Completeness of disclosure of information on the JSC's website: p.1.12. Name of structural divisions, branches, representative offices, subsidiaries and dependent business entities, their phone numbers, addresses (postal and electronic), information about the order of their work; Item 1.31. video about the investment attractiveness of JSC Clause 1.12. The Company does not have structural divisions, branches, representative offices, subsidiaries and dependent business entities, in this regard, there is no information and information about them on the website; item 1.31. The main territory of the society is a categorized object, in this regard, videos are not published on the website, but videos of the media are published. VIII. Assessment of financial results p. 1-p.4. According to the results of the 12 month 2024 year, accounts receivable increased compared to the beginning of the reporting year. There is no overdue debt. The main reason for the increase in accounts receivable:advance payments for raw materials. Accounts payable increased compared to the beginning of the reporting year. There is no overdue debt. The main reason for the increase in creditworthiness is the accrued dividends of shareholders according to the decision of the annual General Meeting of Shareholders dated 06/18/2024.